|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Dec 03, 2019 |
Title |
Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbances |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
The first in vitro tests for developmental toxicity made use of rodent cells. Newer teratology tests, e.g. developed during the ESNATS project, use human cells and measure mechanistic endpoints (such as transcriptome changes). However, the toxicological implications of mechanistic parameters are hard to judge, without functional/morphological endpoints. To address this issue, we developed a new version of the human stem cell-based test STOP-tox(UKN). For this purpose, the capacity of the cells to self-organize to neural rosettes was assessed as functional endpoint: pluripotent stem cells were allowed to differentiate to neuroepithelial cells for six days in the presence or absence of toxicants. Then, both transcriptome changes were measured (standard STOP-tox(UKN)), and cells were allowed to form rosettes. After optimization of staining methods, an imaging algorithm for rosette quantification was implemented and used for an automated rosette formation assay (RoFA). Neural tube toxicants (like valproic acid), which are known to disturb human development at stages when rosette-forming cells are present, were used as positive controls. Established toxicants led to distinctly different tissue organization and differentiation stages. RoFA outcome and transcript changes largely correlated concerning (i) the concentration-dependence, (ii) the time-dependence, and (iii) the set of positive hits identified amongst 24 potential toxicants. Using such comparative data, a prediction model for the RoFA was developed. The comparative analysis was also used to identify gene dysregulations that are particularly predictive for disturbed rosette formation. This ‘RoFA predictor gene set’ may be used for a simplified and less costly setup of the STOP-tox(UKN) assay.
|
|
|
Overall design |
We applied a test system (referred as the STOP-tox(UKN) or UKN1 test system) of developmental toxicity, related to the generation of neuroectoderm from human embryonic stem cells (hESCs), and exposed cells for six days to 24 different compounds (dimethyl sulfoxide, BIO, CHIR99021, lithium chloride, retinoic acid, geldanamycin, galnon, gleevec, estradiol, bisphenol A, interferon beta, cycloporin A/FK506, valproic acid, trichostatin-A, vorinostat, belinostat, panobinostat and entinostat, methylmercury, thimerosal, mercury(II)chloride, mercury(II)bromide, 4-chloromercuribenzoic acid and phenylmercuric acid). After 6 days, total RNA was isolated and gene expression studies were performed applying the human Genome U133 plus 2.0 arrays. Expression changes are always shown relative to an untreated control. At least three independent experiments have been performed.
|
|
|
Contributor(s) |
Sachinidis A, Leist M |
Citation(s) |
31712839 |
|
Submission date |
Dec 02, 2019 |
Last update date |
Mar 04, 2020 |
Contact name |
Marcel Leist |
E-mail(s) |
[email protected]
|
Organization name |
University of Konstanz
|
Lab |
In vitro toxicology and biomedicine
|
Street address |
Universitätsstraße 10
|
City |
Konstanz |
ZIP/Postal code |
78464 |
Country |
Germany |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (148)
|
GSM4199846 |
hESCs, CHIR (0.000002 M) for 6 days, D14_14MK_164 |
GSM4199847 |
hESCs, BIO (0.000002 M) for 6 days, D14_13MK_165 |
GSM4199848 |
hESCs, incubated with culturing medium for 6 days, D15_13MK_166 |
GSM4199849 |
hESCs, CHIR (0.000002 M) for 6 days, D14_14MK_167 |
GSM4199850 |
hESCs, BIO (0.000002 M) for 6 days, D14_14MK_168 |
GSM4199851 |
hESCs, incubated with culturing medium for 6 days, D14_14MK_169 |
GSM4199852 |
hESCs, CHIR (0.000002 M) for 6 days, D14_15MK_170 |
GSM4199853 |
hESCs, BIO (0.000002 M) for 6 days, D14_15MK_171 |
GSM4199854 |
hESCs, incubated with culturing medium for 6 days, D14_15MK_172 |
GSM4199855 |
hESCs, CHIR99021 (0.000002 M) for 6 days, D15_08AH_173 |
GSM4199856 |
hESCs, BIO (0.000002 M) for 6 days, D15_08AH_174 |
GSM4199857 |
hESCs, incubated with culturing medium for 6 days, D15_08AH_175 |
GSM4199858 |
hESCs, LiCl (0.00000001 M) for 6 days, D15_11MK_71 |
GSM4199859 |
hESCs, incubated with culturing medium for 6 days, D15_11MK_79 |
GSM4199860 |
hESCs, LiCl (0.00000001 M) for 6 days, D15_11MK_96 |
GSM4199861 |
hESCs, incubated with culturing medium for 6 days, D15_13MK_100 |
GSM4199862 |
hESCs, LiCl (0.00000001 M) for 6 days, D15_13MK_103 |
GSM4199863 |
hESCs, incubated with culturing medium for 6 days, D15_13MK_107 |
GSM4199864 |
hESCs, incubated with culturing medium for 6 days, D15_14MK_158 |
GSM4199865 |
hESCs, Bisphenol A (0.000000001 M) for 6 days, D15_14MK_160 |
GSM4199866 |
hESCs, LiCl (0.00000001 M) for 6 days, D15_14MK_161 |
GSM4199867 |
hESCs, Estradiol (0.000000001 M) for 6 days, D15_14MK_162 |
GSM4199868 |
hESCs, Bisphenol A (0.000000001 M) for 6 days, D15_16MK_122 |
GSM4199869 |
hESCs, Bisphenol A (0.000000001 M) for 6 days, D15_16MK_123 |
GSM4199870 |
hESCs, incubated with culturing medium for 6 days, D15_16MK_124 |
GSM4199871 |
hESCs, Estradiol (0.000000001 M) for 6 days, D15_16MK_125 |
GSM4199872 |
hESCs, Estradiol (0.000000001 M) for 6 days, D15_16MK_126 |
GSM4199873 |
hESCs, FK506/Cyclosporin A (0.000015 M/ 0.0000025 M) for 6 days, D15_17MK_111 |
GSM4199874 |
hESCs, Estradiol (0.000000001 M) for 6 days, D15_17MK_115 |
GSM4199875 |
hESCs, BPA (0.000000001 M) for 6 days, D15_17MK_116 |
GSM4199876 |
hESCs, incubated with culturing medium for 6 days, D15_17MK_155 |
GSM4199877 |
hESCs, Retionic acid (0.00000001 M) for 6 days, D15_18MK_140 |
GSM4199878 |
hESCs, incubated with culturing medium for 6 days, D15_18MK_143 |
GSM4199879 |
hESCs, Retionic acid (0.00000001 M) for 6 days, D15_19MK_146 |
GSM4199880 |
hESCs, Retionic acid (0.00000001 M) for 6 days, D15_19MK_147 |
GSM4199881 |
hESCs, FK506/Cyclosporin A (0.000015 M/ 0.0000025 M) for 6 days, D15_19MK_151 |
GSM4199882 |
hESCs, FK506/Cyclosporin A (0.000015 M/ 0.0000025 M) for 6 days, D15_19MK_152 |
GSM4199883 |
hESCs, LiCl (0.00000001 M) for 6 days, D15_19MK_154 |
GSM4199884 |
hESCs, incubated with culturing medium for 6 days, D15_19MK_156 |
GSM4199885 |
hESCs, incubated with culturing medium for 6 days, Exp1 |
GSM4199886 |
hESCs, incubated with culturing medium for 6 days, Exp2 |
GSM4199887 |
hESCs, incubated with culturing medium for 6 days, Exp3 |
GSM4199888 |
hESCs, incubated with culturing medium for 6 days, Exp4 |
GSM4199889 |
hESCs, incubated with culturing medium for 6 days, Exp5 |
GSM4199890 |
hESCs, Galnon (0.00001 M) for 6 days, Exp1 |
GSM4199891 |
hESCs, Galnon (0.00001 M) for 6 days, Exp2 |
GSM4199892 |
hESCs, Galnon (0.00001 M) for 6 days, Exp3 |
GSM4199893 |
hESCs, Galnon (0.00001 M) for 6 days, Exp4 |
GSM4199894 |
hESCs, Geldanamycin (0.000000001 M) for 6 days, Exp1 |
GSM4199895 |
hESCs, Geldanamycin (0.000000001 M) for 6 days, Exp2 |
GSM4199896 |
hESCs, Geldanamycin (0.000000001 M) for 6 days, Exp3 |
GSM4199897 |
hESCs, Geldanamycin (0.000000001 M) for 6 days, Exp4 |
GSM4199898 |
hESCs, Geldanamycin (0.000000001 M) for 6 days, Exp5 |
GSM4199899 |
hESCs, Gleevec (0.00001 M) for 6 days, Exp1 |
GSM4199900 |
hESCs, Gleevec (0.00001 M) for 6 days, Exp2 |
GSM4199901 |
hESCs, Gleevec (0.00001 M) for 6 days, Exp3 |
GSM4199902 |
hESCs, Gleevec (0.00001 M) for 6 days, Exp4 |
GSM4199903 |
hESCs, Gleevec (0.00001 M) for 6 days, Exp5 |
GSM4199904 |
hESCs, Interferon beta (0.0000000005 M) for 6 days, Exp1 |
GSM4199905 |
hESCs, Interferon beta (0.0000000005 M) for 6 days, Exp3 |
GSM4199906 |
hESCs, Interferon beta (0.0000000005 M) for 6 days, Exp2 |
GSM4199907 |
hESCs, Interferon beta (0.0000000005 M) for 6 days, Exp4 |
GSM4199908 |
hESCs, Interferon beta (0.0000000005 M) for 6 days, Exp5 |
GSM4200207 |
hESCs, ethanol (MeHg solvent) as a vehicle for 6 days, D11_21 |
GSM4200208 |
hESCs, ethanol (MeHg solvent) as a vehicle for 6 days, D11_22 |
GSM4200209 |
hESCs, ethanol (MeHg solvent) as a vehicle for 6 days, D11_23 |
GSM4200210 |
hESCs, ethanol (MeHg solvent) as a vehicle for 6 days, D11_24 |
GSM4200211 |
hESCs, ethanol (MeHg solvent) as a vehicle for 6 days, D11_25 |
GSM4200212 |
hESCs, MeHg for 6 days, D11_21 |
GSM4200213 |
hESCs, MeHg for 6 days, D11_22 |
GSM4200214 |
hESCs, MeHg for 6 days, D11_23 |
GSM4200215 |
hESCs, MeHg for 6 days, D11_24 |
GSM4200216 |
hESCs, MeHg for 6 days, D11_25 |
GSM4200217 |
hESCs, DMSO (trichostatin-A solvent) as a vehicle for 6 days, D11_21 |
GSM4200218 |
hESCs, DMSO (trichostatin-A solvent) as a vehicle for 6 days, D11_22 |
GSM4200219 |
hESCs, DMSO (trichostatin-A solvent) as a vehicle for 6 days, D11_23 |
GSM4200220 |
hESCs, DMSO (trichostatin-A solvent) as a vehicle for 6 days, D11_24 |
GSM4200221 |
hESCs, DMSO (trichostatin-A solvent) as a vehicle for 6 days, D11_25 |
GSM4200222 |
hESCs, trichostatin-A for 6 days, D11_21 |
GSM4200223 |
hESCs, trichostatin-A for 6 days, D11_22 |
GSM4200224 |
hESCs, trichostatin-A for 6 days, D11_23 |
GSM4200225 |
hESCs, trichostatin-A for 6 days, D11_24 |
GSM4200226 |
hESCs, trichostatin-A for 6 days, D11_25 |
GSM4200227 |
hESCs, culturing medium for 6 days, D11_21 |
GSM4200228 |
hESCs, culturing medium for 6 days, D11_22 |
GSM4200229 |
hESCs, culturing medium for 6 days, D11_23 |
GSM4200230 |
hESCs, culturing medium for 6 days, D11_24 |
GSM4200231 |
hESCs, culturing medium for 6 days, D11_25 |
GSM4200232 |
hESCs, culturing medium for 6 days, D12_07 |
GSM4200233 |
hESCs, culturing medium for 6 days, D12_08 |
GSM4200234 |
hESCs, culturing medium for 6 days, D12_09 |
GSM4200235 |
hESCs, culturing medium for 6 days, D12_10 |
GSM4200236 |
hESCs, valproic acid for 6 days, D12_07 |
GSM4200237 |
hESCs, valproic acid for 6 days, D12_08 |
GSM4200238 |
hESCs, valproic acid for 6 days, D12_09 |
GSM4200239 |
hESCs, valproic acid for 6 days, D12_10 |
GSM4200240 |
hESCs, DMSO (suberanilohydroxamic acid solvent) as a vehicle for 6 days, D12_18 |
GSM4200241 |
hESCs, DMSO (suberanilohydroxamic acid solvent) as a vehicle for 6 days, D12_19 |
GSM4200242 |
hESCs, DMSO (suberanilohydroxamic acid solvent) as a vehicle for 6 days, D12_20 |
GSM4200243 |
hESCs, DMSO (suberanilohydroxamic acid solvent) as a vehicle for 6 days, D12_21 |
GSM4200244 |
hESCs, suberanilohydroxamic acid for 6 days, D12_18 |
GSM4200245 |
hESCs, suberanilohydroxamic acid for 6 days, D12_19 |
GSM4200246 |
hESCs, suberanilohydroxamic acid for 6 days, D12_20 |
GSM4200247 |
hESCs, suberanilohydroxamic acid for 6 days, D12_21 |
GSM4200248 |
hESCs, culturing medium for 6 days, D12_18 |
GSM4200249 |
hESCs, culturing medium for 6 days, D12_19 |
GSM4200250 |
hESCs, culturing medium for 6 days, D12_20 |
GSM4200251 |
hESCs, culturing medium for 6 days, D12_21 |
GSM4200252 |
hESCs, thimerosal for 6 days, D12_18 |
GSM4200253 |
hESCs, thimerosal for 6 days, D12_19 |
GSM4200254 |
hESCs, thimerosal for 6 days, D12_20 |
GSM4200255 |
hESCs, thimerosal for 6 days, D12_21 |
GSM4200256 |
hESCs, HgCl2 for 6 days, D12_18 |
GSM4200257 |
hESCs, HgCl2 for 6 days, D12_19 |
GSM4200258 |
hESCs, HgCl2 for 6 days, D12_20 |
GSM4200259 |
hESCs, HgCl2 for 6 days, D12_21 |
GSM4200260 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_2.1 |
GSM4200261 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_2.2 |
GSM4200262 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_2.3 |
GSM4200263 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_2.4 |
GSM4200264 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_6.1 |
GSM4200265 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_6.2 |
GSM4200266 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_6.3 |
GSM4200267 |
hESCs, culturing medium for 6 days, Tanja_Waldmann_6.4 |
GSM4200268 |
hESCs, belinostat for 6 days, Tanja_Waldmann_1.1 |
GSM4200269 |
hESCs, belinostat for 6 days, Tanja_Waldmann_1.2 |
GSM4200270 |
hESCs, belinostat for 6 days, Tanja_Waldmann_1.3 |
GSM4200271 |
hESCs, belinostat for 6 days, Tanja_Waldmann_1.4 |
GSM4200272 |
hESCs, panobinostat for 6 days, Tanja_Waldmann_3.1 |
GSM4200273 |
hESCs, panobinostat for 6 days, Tanja_Waldmann_3.2 |
GSM4200274 |
hESCs, panobinostat for 6 days, Tanja_Waldmann_3.3 |
GSM4200275 |
hESCs, panobinostat for 6 days, Tanja_Waldmann_3.4 |
GSM4200276 |
hESCs, HgBr2 for 6 days, Tanja_Waldmann_4.1 |
GSM4200277 |
hESCs, HgBr2 for 6 days, Tanja_Waldmann_4.2 |
GSM4200278 |
hESCs, HgBr2 for 6 days, Tanja_Waldmann_4.3 |
GSM4200279 |
hESCs, HgBr2 for 6 days, Tanja_Waldmann_4.4 |
GSM4200280 |
hESCs, entinostat for 6 days, Tanja_Waldmann_5.1 |
GSM4200281 |
hESCs, entinostat for 6 days, Tanja_Waldmann_5.2 |
GSM4200282 |
hESCs, entinostat for 6 days, Tanja_Waldmann_5.3 |
GSM4200283 |
hESCs, entinostat for 6 days, Tanja_Waldmann_5.4 |
GSM4200284 |
hESCs, phenylmercuric acetate for 6 days, Tanja_Waldmann_7.1 |
GSM4200285 |
hESCs, phenylmercuric acetate for 6 days, Tanja_Waldmann_7.2 |
GSM4200286 |
hESCs, phenylmercuric acetate for 6 days, Tanja_Waldmann_7.3 |
GSM4200287 |
hESCs, phenylmercuric acetate for 6 days, Tanja_Waldmann_7.4 |
GSM4200288 |
hESCs, 4-chloromercuribenzoic acid for 6 days, Tanja_Waldmann_8.1 |
GSM4200289 |
hESCs, 4-chloromercuribenzoic acid for 6 days, Tanja_Waldmann_8.2 |
GSM4200290 |
hESCs, 4-chloromercuribenzoic acid for 6 days, Tanja_Waldmann_8.3 |
GSM4200291 |
hESCs, 4-chloromercuribenzoic acid for 6 days, Tanja_Waldmann_8.4 |
|
Relations |
BioProject |
PRJNA592964 |
Supplementary file |
Size |
Download |
File type/resource |
GSE141253_RAW.tar |
662.7 Mb |
(http)(custom) |
TAR (of CEL) |
Processed data included within Sample table |
|
|
|
|
|